Hani Luxenburg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hani Luxenburg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hani Luxenburg Today - Breaking & Trending Today

MediWound to Report First Quarter 2024 Financial Results

Published: May 22, 2024

Conference Call and Webcast Scheduled for Wednesday, May 29th at 8:30 am Eastern Time...

Source: globenewswire.com

MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns

Published: January 9, 2024

If approved, NexoBrid will serve as an effective non-surgical treatment for both pediatric and adult burn patients in the U.S. NexoBrid is already approved for use for burn patients across all age groups in Europe and Japan YAVNE, Israel, Jan. 09, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Food and Drug Administration (FDA) has completed the

Source: yahoo.com

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army

Published: December 28, 2023

Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 millionYAVNE, Israel, Dec. 28, 2023 -- MediWound Ltd. , a...

Source: marketscreener.com

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® ...

Published: December 28, 2023

YAVNE, Israel, Dec. 28, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Department

Source: bdtonline.com

MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update

Published: November 21, 2023

NexoBrid® commercially launched in U.S. and Japan; Company prioritizes operational resources to meet increased global demand EscharEx® Phase III study preparations progressing; Protocol...